Novo Nordisk and Eli Lilly rival soars 26% after promising test results By: CNBC.com News February 26, 2024 at 05:30 AM EST Zealand Pharma's Phase 2 trial was an "uniquivocal win" for a drug that can treat both liver disease and obesity, analysts said. Read More >>
